Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. [electronic resource] by
- Bokemeyer, Dirk
- Panek, Darius
- Kramer, Herbert J
- Lindemann, Marion
- Kitahara, Masashi
- Boor, Peter
- Kerjaschki, Dontscho
- Trzaskos, James M
- Floege, Jürgen
- Ostendorf, Tammo
Producer: 20021104
In:
Journal of the American Society of Nephrology : JASN vol. 13
Availability: No items available.
|
|
11.
|
The map kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis. [electronic resource] by
- Bokemeyer, Dirk
- Panek, Darius
- Kitahara, Masashi
- Trzaskos, James M
- Müller, Christa E
- Hockemeyer, Jörg
- Kunter, Uta
- Boor, Peter
- Floege, Jürgen
- Kramer, Herbert J
- Ostendorf, Tammo
Producer: 20080513
In:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 22
Availability: No items available.
|
|
12.
|
Aggrecan protects cartilage collagen from proteolytic cleavage. [electronic resource] by
- Pratta, Michael A
- Yao, Wenqing
- Decicco, Carl
- Tortorella, Micky D
- Liu, Riu-Qin
- Copeland, Robert A
- Magolda, Ronald
- Newton, Robert C
- Trzaskos, James M
- Arner, Elizabeth C
Producer: 20031224
In:
The Journal of biological chemistry vol. 278
Availability: No items available.
|
|
13.
|
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents. [electronic resource] by
- Ott, Gregory R
- Asakawa, Naoyuki
- Lu, Zhonghui
- Anand, Rajan
- Liu, Rui-Qin
- Covington, Maryanne B
- Vaddi, Krishna
- Qian, Mingxin
- Newton, Robert C
- Christ, David D
- Trzaskos, James M
- Duan, James J-W
Producer: 20080519
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|
|
14.
|
N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists. [electronic resource] by
- Batt, Douglas G
- Houghton, Gregory C
- Roderick, John
- Santella, Joseph B
- Wacker, Dean A
- Welch, Patricia K
- Orlovsky, Yevgeniya I
- Wadman, Eric A
- Trzaskos, James M
- Davies, Paul
- Decicco, Carl P
- Carter, Percy H
Producer: 20050607
In:
Bioorganic & medicinal chemistry letters vol. 15
Availability: No items available.
|
|
15.
|
Sultam hydroxamates as novel matrix metalloproteinase inhibitors. [electronic resource] by
- Cherney, Robert J
- Mo, Ruowei
- Meyer, Dayton T
- Hardman, Karl D
- Liu, Rui-Qin
- Covington, Maryanne B
- Qian, Mingxin
- Wasserman, Zelda R
- Christ, David D
- Trzaskos, James M
- Newton, Robert C
- Decicco, Carl P
Producer: 20040702
In:
Journal of medicinal chemistry vol. 47
Availability: No items available.
|
|
16.
|
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). [electronic resource] by
- Ott, Gregory R
- Asakawa, Naoyuki
- Liu, Rui-Qin
- Covington, Maryanne B
- Qian, Mingxin
- Vaddi, Krishna
- Newton, Robert C
- Trzaskos, James M
- Christ, David D
- Galya, Laurine
- Scholz, Thomas
- Marshall, Will
- Duan, James J-W
Producer: 20080512
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|
|
17.
|
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification. [electronic resource] by
- Xue, Chu-Biao
- He, Xiaohua
- Roderick, John
- Corbett, Ronald L
- Duan, James J-W
- Liu, Rui-Qin
- Covington, Maryanne B
- Newton, Robert C
- Trzaskos, James M
- Magolda, Ronald L
- Wexler, Ruth R
- Decicco, Carl P
Producer: 20040806
In:
Bioorganic & medicinal chemistry letters vol. 13
Availability: No items available.
|
|
18.
|
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors. [electronic resource] by
- Duan, James J-W
- Chen, Lihua
- Lu, Zhonghui
- Xue, Chu-Biao
- Liu, Rui-Qin
- Covington, Maryanne B
- Qian, Mingxin
- Wasserman, Zelda R
- Vaddi, Krishna
- Christ, David D
- Trzaskos, James M
- Newton, Robert C
- Decicco, Carl P
Producer: 20080212
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|
|
19.
|
Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). [electronic resource] by
- Duan, James J-W
- Lu, Zhonghui
- Xue, Chu-Biao
- He, Xiaohua
- Seng, Jennifer L
- Roderick, John J
- Wasserman, Zelda R
- Liu, Rui-Qin
- Covington, Maryanne B
- Magolda, Ronald L
- Newton, Robert C
- Trzaskos, James M
- Decicco, Carl P
Producer: 20040211
In:
Bioorganic & medicinal chemistry letters vol. 13
Availability: No items available.
|
|
20.
|
Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonists. [electronic resource] by
- Voss, Matthew E
- Carter, Percy H
- Tebben, Andrew J
- Scherle, Peggy A
- Brown, Gregory D
- Thompson, Lorin A
- Xu, Meizhong
- Lo, Yvonne C
- Yang, Gengjie
- Liu, Rui-Qin
- Strzemienski, Paul
- Everlof, J Gerry
- Trzaskos, James M
- Decicco, Carl P
Producer: 20030815
In:
Bioorganic & medicinal chemistry letters vol. 13
Availability: No items available.
|